NM_139076.3:c.1117G>A
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_139076.3(ABRAXAS1):c.1117G>A(p.Asp373Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0504 in 1,614,020 control chromosomes in the GnomAD database, including 2,409 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D373G) has been classified as Uncertain significance.
Frequency
Consequence
NM_139076.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_139076.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ABRAXAS1 | NM_139076.3 | MANE Select | c.1117G>A | p.Asp373Asn | missense | Exon 9 of 9 | NP_620775.2 | ||
| ABRAXAS1 | NM_001345962.2 | c.790G>A | p.Asp264Asn | missense | Exon 8 of 8 | NP_001332891.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ABRAXAS1 | ENST00000321945.12 | TSL:1 MANE Select | c.1117G>A | p.Asp373Asn | missense | Exon 9 of 9 | ENSP00000369857.3 | ||
| ABRAXAS1 | ENST00000506553.5 | TSL:5 | c.970G>A | p.Asp324Asn | missense | Exon 9 of 9 | ENSP00000426763.1 | ||
| ABRAXAS1 | ENST00000475656.6 | TSL:2 | n.*825G>A | non_coding_transcript_exon | Exon 8 of 8 | ENSP00000426080.1 |
Frequencies
GnomAD3 genomes AF: 0.0419 AC: 6382AN: 152136Hom.: 192 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0440 AC: 11060AN: 251372 AF XY: 0.0446 show subpopulations
GnomAD4 exome AF: 0.0513 AC: 75042AN: 1461766Hom.: 2217 Cov.: 31 AF XY: 0.0506 AC XY: 36760AN XY: 727188 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0419 AC: 6377AN: 152254Hom.: 192 Cov.: 33 AF XY: 0.0433 AC XY: 3220AN XY: 74428 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
not specified Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
ABRAXAS1-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
Hereditary cancer-predisposing syndrome Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at